Inventor · disambiguated record
Charles L. Sawyers
Also filed as: SAWYERS CHARLES · SAWYERS CHARLES L
37 granted patents·25 pending applications·557 citations·filing 1997–2025
98Inventor score
Files withUNIV CALIFORNIA35SAWYERS CHARLES L9MEMORIAL SLOAN KETTERING CANCER CENTER6JUNG MICHAEL E4SLOAN KETTERING INST CANCER3
Top patents by PatentIndex Score
62 records- 0198US7709517B2Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2006·Granted May 4, 2010·99 cites·13 claims
- 0297US8445507B2Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseasesJUNG MICHAEL E·Filed 2007·Granted May 21, 2013·73 cites·31 claims
- 0396US8183274B2Treatment of hyperproliferative disorders with diarylhydantoin compoundsSAWYERS CHARLES L·Filed 2010·Granted May 22, 2012·42 cites·40 claims
- 0496US6828471B2Mice models of human prostate cancerUNIV CALIFORNIA·Filed 2002·Granted Dec 7, 2004·44 cites·6 claims
- 0595US9126941B2Treatment of hyperproliferative disorders with diarylhydantoin compoundsSAWYERS CHARLES L·Filed 2012·Granted Sep 8, 2015·26 cites·32 claims
- 0695US8802689B2Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseasesJUNG MICHAEL E·Filed 2012·Granted Aug 12, 2014·25 cites·19 claims
- 0794US9987261B2Substituted diazaspiroalkanes as androgen receptor modulatorsUNIV CALIFORNIA·Filed 2016·Granted Jun 5, 2018·12 cites·21 claims
- 0893US9388159B2Substituted diazaspiroalkanes as androgen receptor modulatorsUNIV CALIFORNIA·Filed 2014·Granted Jul 12, 2016·15 cites·33 claims
- 0993US8110594B2Diarylthiohydantoin compoundsJUNG MICHAEL E·Filed 2007·Granted Feb 7, 2012·26 cites·51 claims
- 1092US10857139B2Substituted diazaspiroalkanes as androgen receptor modulatorsUNIV CALIFORNIA·Filed 2018·Granted Dec 8, 2020·4 cites·15 claims
- 1192US7718684B2Methods and materials for assessing prostate cancer therapies and compoundsUNIV CALIFORNIA·Filed 2005·Granted May 18, 2010·13 cites·13 claims
- 1291US8648105B2Diarylthiohydantoin compoundsJUNG MICHAEL E·Filed 2011·Granted Feb 11, 2014·18 cites·27 claims
- 1388US9365542B2Modulators of resistant androgen receptorSLOAN KETTERING INST CANCER·Filed 2013·Granted Jun 14, 2016·4 cites·5 claims
- 1487US7053263B2Mouse models of human prostate cancer progressionUNIV CALIFORNIA·Filed 2001·Granted May 30, 2006·18 cites·7 claims
- 1587US2024293383A1Substituted diazaspiroalkanes as androgen receptor modulatorsUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 1686US6093800AE25a protein, methods for production and use thereofUNIV CALIFORNIA·Filed 1997·Granted Jul 25, 2000·42 cites·1 claims
- 1786US2024132452A1Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 1885US7030232B1E25A protein, methods for producing and use thereofUNIV CALIFORNIA·Filed 1999·Granted Apr 18, 2006·39 cites·15 claims
- 1984US9650359B2Modulators of resistant androgen receptorMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted May 16, 2017·2 cites·10 claims
- 2083US8697348B2Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571SAWYERS CHARLES L·Filed 2006·Granted Apr 15, 2014·2 cites·7 claims
- 2182US2023109968A1Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 2280US7521175B2Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571UNIV CALIFORNIA·Filed 2002·Granted Apr 21, 2009·12 cites·31 claims
- 2380US7122714B2Mouse models of human prostate cancerUNIV CALIFORNIA·Filed 2002·Granted Oct 17, 2006·5 cites·6 claims
- 2479US10450294B2Modulators of resistant androgen receptorMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Oct 22, 2019·1 cites·18 claims
- 2579US6365797B1Mice models of human prostate cancer progressionUNIV CALIFORNIA·Filed 2000·Granted Apr 2, 2002·18 cites·17 claims
- 2678US11446400B2Free PSA antibodies as diagnostics, prognostics and therapeutics for prostate cancerMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Sep 20, 2022·1 cites·8 claims
- 2778US9056924B2Mutations in the BCR-ABL tyrosine kinase associated with resistance to STI-571SAWYERS CHARLES L·Filed 2008·Granted Jun 16, 2015·2 cites·42 claims
- 2878US6949690B2Methods of assessing the effect of a gene of interest on human prostate cancer progressionUNIV CALIFORNIA·Filed 2002·Granted Sep 27, 2005·4 cites·6 claims
- 2978US2025333385A1Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2025·Application pending·0 cites
- 3075US11771687B2Substituted diazaspiroalkanes as androgen receptor modulatorsUNIV CALIFORNIA·Filed 2020·Granted Oct 3, 2023·0 cites·28 claims
- 3175US2021238145A1Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 3274US8586291B2Mutations in the Bcr-Abl tyrosine kinase associated with resistance to ST1-571SAWYERS CHARLES L·Filed 2009·Granted Nov 19, 2013·0 cites·18 claims
- 3373US2023040245A1Free psa antibodies as diagnostics, prognostics and therapeutics for prostate cancerMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 3472US2020079741A1Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 3571US11739069B2Modulators of resistant androgen receptorMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Aug 29, 2023·0 cites·9 claims
- 3670US2019210974A1Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 3769US2019144946A1Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571UNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 3868US9085644B2Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571SAWYERS CHARLES L·Filed 2012·Granted Jul 21, 2015·0 cites·3 claims
- 3967US2015112082A1Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2014·Application pending·0 cites
- 4066US6956145B2Mice models of human prostate cancer progressionUNIV CALIFORNIA·Filed 2002·Granted Oct 18, 2005·4 cites·7 claims
- 4166US6815574B2Methods of simulating human prostate cancer progressionUNIV CALIFORNIA·Filed 2002·Granted Nov 9, 2004·4 cites·14 claims
- 4266US2018086718A1Diarylhydantoin CompoundsUNIV CALIFORNIA·Filed 2017·Application pending·0 cites
- 4365US10919929B2Glucocorticoid inhibitors for treatment of prostate cancerSLOAN KETTERING INST CANCER RES·Filed 2014·Granted Feb 16, 2021·0 cites·7 claims
- 4464US9994910B2Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571UNIV CALIFORNIA·Filed 2015·Granted Jun 12, 2018·0 cites·30 claims
- 4563US2013034501A1Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2012·Application pending·0 cites
- 4661US7595431B2Mouse models of human prostate cancerUNIV CALIFORNIA·Filed 2006·Granted Sep 29, 2009·0 cites·11 claims
- 4760US2012021425A1Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571SAWYERS CHARLES L·Filed 2011·Application pending·0 cites
- 4858US2007253953A1Molecular Signature of the Pten Tumor SuppressorUNIV CALIFORNIA·Filed 2004·Application pending·0 cites
- 4957US8034548B2Methods and materials for assessing prostate cancer therapiesUNIV CALIFORNIA·Filed 2004·Granted Oct 11, 2011·2 cites·9 claims
- 5057US2021179660A1Glucocorticoid inhibitors for treatment of prostate cancerSLOAN KETTERING INST CANCER RES·Filed 2020·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Charles L. Sawyers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →